Chronic prostatitis/chronic pelvic pain syndrome

被引:0
|
作者
Magistro, G. [1 ,3 ]
Wagenlehner, F. M. E. [2 ]
Pilatz, A. [2 ]
机构
[1] Asklepios Westklinikum Hamburg, Urol Klin, Hamburg, Germany
[2] Justus Liebig Univ Giessen, Klin & Poliklin Urol Kinderurol & Androl, Giessen, Germany
[3] Asklepios Westklinikum Hamburg, Urol Klin, Suurheid 20, D-22559 Hamburg, Germany
来源
UROLOGIE | 2023年 / 62卷 / 06期
关键词
Multimodal treatment; Quality of life; Urogenital system; Lower urinary tract symptoms; Urinary tract infections; QUALITY-OF-LIFE; SEXUAL DYSFUNCTION; SYMPTOM INDEX; BACTERIAL PROSTATITIS; MEN; HEALTH; UPOINT; CLASSIFICATION; PREVALENCE; PREDICTORS;
D O I
10.1007/s00120-023-02089-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is defined as chronic pain or discomfort in the pelvic region for at least 3 of the past 6 months. It is variably associated with lower urinary tract symptoms, psychosocial consequences, and sexual dysfunction. Specific test systems or biomarkers for a definitive diagnosis are still not available. The purposes of the basic diagnostic assessment are to determine the individual spectrum of symptoms and to rule out differential diagnoses of pelvic pain. Patient-reported outcome measures (PROMs) like the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) are valuable instruments for the initial diagnostic assessment and to evaluate treatment response. Classification systems like UPOINTS (urinary, psychosocial, organ specific, infection, neurologic/systemic, tenderness of skeletal muscles, sexual dysfunction) are valuable tools to determine the individual spectrum of symptoms, to guide the adapted diagnostic assessment, and to identify relevant targets for a multimodal and tailored treatment. Close urological monitoring of CP/CPPS patients is usually necessary, especially to minimize the unwarranted use of antibiotics in the case of undulating complaints.
引用
收藏
页码:590 / 596
页数:7
相关论文
共 50 条
  • [31] Alfuzosin in the treatment of chronic prostatitis/chronic pelvic pain syndrome
    Pontari M.
    [J]. Current Bladder Dysfunction Reports, 2009, 4 (3) : 121 - 121
  • [32] New treatments for chronic prostatitis/chronic pelvic pain syndrome
    Strauss, Adam C.
    Dimitrakov, Jordan D.
    [J]. NATURE REVIEWS UROLOGY, 2010, 7 (03) : 127 - 135
  • [33] Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome
    Magistro, Giuseppe
    Wagenlehner, Florian M. E.
    Grabe, Magnus
    Weidner, Wolfgang
    Stief, Christian G.
    Nickel, J. Curtis
    [J]. EUROPEAN UROLOGY, 2016, 69 (02) : 286 - 297
  • [34] Multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome
    Robert F. Donnell
    [J]. Current Urology Reports, 2004, 5 (4) : 299 - 299
  • [35] The impact of chronic prostatitis/chronic pelvic pain syndrome on patients
    Mary McNaughton Collins
    [J]. World Journal of Urology, 2003, 21 : 86 - 89
  • [36] Etiologic theories of chronic prostatitis/chronic pelvic pain syndrome
    Pontari M.A.
    [J]. Current Urology Reports, 2007, 8 (4) : 307 - 312
  • [37] Management of chronic prostatitis-chronic pelvic pain syndrome
    Anderson, RU
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2002, 29 (01) : 235 - +
  • [38] Gut microbiome and chronic prostatitis/chronic pelvic pain syndrome
    Arora, Hans C.
    Eng, Charis
    Shoskes, Daniel A.
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (02)
  • [39] Symptomatic approach to chronic prostatitis/chronic pelvic pain syndrome
    Delavierre, D.
    Rigaud, J.
    Sibert, L.
    Labat, J. -J.
    [J]. PROGRES EN UROLOGIE, 2010, 20 (12): : 940 - 953
  • [40] Diagnosis and treatment of chronic prostatitis/chronic pelvic pain syndrome
    Rees, Jonathan
    Doble, Andrew
    [J]. TRENDS IN UROLOGY & MENS HEALTH, 2015, 6 (01) : 12 - 17